United States Brucellosis Vaccines Market Report 2016

Publisher Name :
Date: 13-Sep-2016
No. of pages: 124
Inquire Before Buying

Notes:

Sales, means the sales volume of Brucellosis Vaccines

Revenue, means the sales value of Brucellosis Vaccines

This report studies sales (consumption) of Brucellosis Vaccines in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Bayer HealthCare AG (Germany)

- Biogenesis-Bago (Argentina)

- Boehringer Ingelheim GmbH (Germany)

- Ceva Sante Animale (France)

- Heska Corporation (US)

- Indian Immunologicals Ltd (India)

- Lohmann Animal Health (US)

- Merck Animal Health (US)

- Merial Ltd. (US)

- Protein Sciences Corporation (US)

- Virbac SA (France)

- Zoetis Inc. (US)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Brucellosis Vaccines in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Brucellosis Vaccines Market Report 2016

Table of Contents
United States Brucellosis Vaccines Market Report 2016
1 Brucellosis Vaccines Overview
1.1 Product Overview and Scope of Brucellosis Vaccines
1.2 Classification of Brucellosis Vaccines
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Brucellosis Vaccines
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Brucellosis Vaccines (2011-2021)
1.4.1 USA Brucellosis Vaccines Sales and Growth Rate (2011-2021)
1.4.2 USA Brucellosis Vaccines Revenue and Growth Rate (2011-2021)
2 USA Brucellosis Vaccines Competition by Manufacturers
2.1 USA Brucellosis Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Brucellosis Vaccines Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Brucellosis Vaccines Average Price by Manufactures (2015 and 2016)
2.4 Brucellosis Vaccines Market Competitive Situation and Trends
2.4.1 Brucellosis Vaccines Market Concentration Rate
2.4.2 Brucellosis Vaccines Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 USA Brucellosis Vaccines Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 USA Brucellosis Vaccines Sales and Market Share by Type (2011-2016)
3.2 USA Brucellosis Vaccines Revenue and Market Share by Type (2011-2016)
3.3 USA Brucellosis Vaccines Price by Type (2011-2016)
3.4 USA Brucellosis Vaccines Sales Growth Rate by Type (2011-2016)
4 USA Brucellosis Vaccines Sales (Volume) by Application (2011-2016)
4.1 USA Brucellosis Vaccines Sales and Market Share by Application (2011-2016)
4.2 USA Brucellosis Vaccines Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 USA Brucellosis Vaccines Manufacturers Profiles/Analysis
5.1 Bayer HealthCare AG (Germany)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Brucellosis Vaccines Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Bayer HealthCare AG (Germany) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Biogenesis-Bago (Argentina)
5.2.2 Brucellosis Vaccines Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Biogenesis-Bago (Argentina) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Boehringer Ingelheim GmbH (Germany)
5.3.2 Brucellosis Vaccines Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Boehringer Ingelheim GmbH (Germany) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Ceva Sante Animale (France)
5.4.2 Brucellosis Vaccines Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Ceva Sante Animale (France) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Heska Corporation (US)
5.5.2 Brucellosis Vaccines Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Heska Corporation (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Indian Immunologicals Ltd (India)
5.6.2 Brucellosis Vaccines Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Indian Immunologicals Ltd (India) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Lohmann Animal Health (US)
5.7.2 Brucellosis Vaccines Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Lohmann Animal Health (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Merck Animal Health (US)
5.8.2 Brucellosis Vaccines Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Merck Animal Health (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Merial Ltd. (US)
5.9.2 Brucellosis Vaccines Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Merial Ltd. (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Protein Sciences Corporation (US)
5.10.2 Brucellosis Vaccines Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Protein Sciences Corporation (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Virbac SA (France)
5.12 Zoetis Inc. (US)
6 Brucellosis Vaccines Manufacturing Cost Analysis
6.1 Brucellosis Vaccines Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Brucellosis Vaccines
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Brucellosis Vaccines Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Brucellosis Vaccines Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 USA Brucellosis Vaccines Market Forecast (2016-2021)
10.1 USA Brucellosis Vaccines Sales, Revenue Forecast (2016-2021)
10.2 USA Brucellosis Vaccines Sales Forecast by Type (2016-2021)
10.3 USA Brucellosis Vaccines Sales Forecast by Application (2016-2021)
10.4 Brucellosis Vaccines Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Brucellosis Vaccines
Table Classification of Brucellosis Vaccines
Figure USA Sales Market Share of Brucellosis Vaccines by Type in 2015
Table Application of Brucellosis Vaccines
Figure USA Sales Market Share of Brucellosis Vaccines by Application in 2015
Figure USA Brucellosis Vaccines Sales and Growth Rate (2011-2021)
Figure USA Brucellosis Vaccines Revenue and Growth Rate (2011-2021)
Table USA Brucellosis Vaccines Sales of Key Manufacturers (2015 and 2016)
Table USA Brucellosis Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Brucellosis Vaccines Sales Share by Manufacturers
Figure 2016 Brucellosis Vaccines Sales Share by Manufacturers
Table USA Brucellosis Vaccines Revenue by Manufacturers (2015 and 2016)
Table USA Brucellosis Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Brucellosis Vaccines Revenue Share by Manufacturers
Table 2016 USA Brucellosis Vaccines Revenue Share by Manufacturers
Table USA Market Brucellosis Vaccines Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Brucellosis Vaccines Average Price of Key Manufacturers in 2015
Figure Brucellosis Vaccines Market Share of Top 3 Manufacturers
Figure Brucellosis Vaccines Market Share of Top 5 Manufacturers
Table USA Brucellosis Vaccines Sales by Type (2011-2016)
Table USA Brucellosis Vaccines Sales Share by Type (2011-2016)
Figure USA Brucellosis Vaccines Sales Market Share by Type in 2015
Table USA Brucellosis Vaccines Revenue and Market Share by Type (2011-2016)
Table USA Brucellosis Vaccines Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Brucellosis Vaccines by Type (2011-2016)
Table USA Brucellosis Vaccines Price by Type (2011-2016)
Figure USA Brucellosis Vaccines Sales Growth Rate by Type (2011-2016)
Table USA Brucellosis Vaccines Sales by Application (2011-2016)
Table USA Brucellosis Vaccines Sales Market Share by Application (2011-2016)
Figure USA Brucellosis Vaccines Sales Market Share by Application in 2015
Table USA Brucellosis Vaccines Sales Growth Rate by Application (2011-2016)
Figure USA Brucellosis Vaccines Sales Growth Rate by Application (2011-2016)
Table Bayer HealthCare AG (Germany) Basic Information List
Table Bayer HealthCare AG (Germany) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare AG (Germany) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Biogenesis-Bago (Argentina) Basic Information List
Table Biogenesis-Bago (Argentina) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biogenesis-Bago (Argentina) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Basic Information List
Table Boehringer Ingelheim GmbH (Germany) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Ceva Sante Animale (France) Basic Information List
Table Ceva Sante Animale (France) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ceva Sante Animale (France) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Heska Corporation (US) Basic Information List
Table Heska Corporation (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Heska Corporation (US) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Indian Immunologicals Ltd (India) Basic Information List
Table Indian Immunologicals Ltd (India) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Indian Immunologicals Ltd (India) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Lohmann Animal Health (US) Basic Information List
Table Lohmann Animal Health (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lohmann Animal Health (US) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Merck Animal Health (US) Basic Information List
Table Merck Animal Health (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Animal Health (US) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Merial Ltd. (US) Basic Information List
Table Merial Ltd. (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merial Ltd. (US) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Protein Sciences Corporation (US) Basic Information List
Table Protein Sciences Corporation (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Protein Sciences Corporation (US) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Virbac SA (France) Basic Information List
Table Virbac SA (France) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Virbac SA (France) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Zoetis Inc. (US) Basic Information List
Table Zoetis Inc. (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zoetis Inc. (US) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Brucellosis Vaccines
Figure Manufacturing Process Analysis of Brucellosis Vaccines
Figure Brucellosis Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Brucellosis Vaccines Major Manufacturers in 2015
Table Major Buyers of Brucellosis Vaccines
Table Distributors/Traders List
Figure USA Brucellosis Vaccines Production and Growth Rate Forecast (2016-2021)
Figure USA Brucellosis Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table USA Brucellosis Vaccines Production Forecast by Type (2016-2021)
Table USA Brucellosis Vaccines Consumption Forecast by Application (2016-2021)
  • Global Bioactive Wound Management Sales Market Report 2017
    Published: 17-Nov-2017        Price: US 4000 Onwards        Pages: 100
    In this report, the global Bioactive Wound Management market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Bioactive Wound Management for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe......
  • Global DNA Probe-based Diagnostic Market Size, Status and Forecast 2022
    Published: 17-Nov-2017        Price: US 3300 Onwards        Pages: 97
    This report studies the global DNA Probe-based Diagnostic market, analyzes and researches the DNA Probe-based Diagnostic development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Abbott Laboratories - BD - Thermo Fisher Scientific - F. Hoffmann La Roche - Luminex - bioMerieux - BioGenex US - MP Biomedicals - Biolegio - GE Health......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Prostaglandin Market 2017 Forecast to 2022
    Published: 17-Nov-2017        Price: US 4880 Onwards        Pages: 115
    "This report studies the Prostaglandin market. Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Pros......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Precision Medicine Market 2017 Forecast to 2022
    Published: 17-Nov-2017        Price: US 4880 Onwards        Pages: 119
    According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Follicle Stimulating Hormone Market 2017 Forecast to 2022
    Published: 17-Nov-2017        Price: US 4880 Onwards        Pages: 115
    "This report studies the follicle stimulating hormone market. Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles. In this report, it refers to follicle stimulating hormone drugs for human use. 1 dose is equal to 75 IU." Scope of the Report: This report focuses on the Follicle Stimulating Hormone in Global market, especia......
  • Global Biological Bone Repair Materials Market Research Report 2017
    Published: 17-Nov-2017        Price: US 2900 Onwards        Pages: 114
    In this report, the global Biological Bone Repair Materials market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Biological Bone Repair Materials in these regions, from 2012 to 2022 (forecast), covering - North America - ......
  • Global Medical Elastic Bandage Market Research Report 2017
    Published: 17-Nov-2017        Price: US 2900 Onwards        Pages: 114
    In this report, the global Medical Elastic Bandage market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Medical Elastic Bandage in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - Ch......
  • Global Plasma Thromboplastin Antecedent Market Research Report 2017
    Published: 17-Nov-2017        Price: US 2900 Onwards        Pages: 108
    In this report, the global Plasma Thromboplastin Antecedent market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Plasma Thromboplastin Antecedent in these regions, from 2012 to 2022 (forecast), covering - North America - ......
  • Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Research Report 2017
    Published: 17-Nov-2017        Price: US 2900 Onwards        Pages: 107
    In this report, the global Female Hypoactive Sexual Desire Disorder Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Female Hypoactive Sexual Desire Disorder Therapeutics in these regions, from 2012 to 2022 (forecast),......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs